Jackson Square Capital LLC Has $2.50 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jackson Square Capital LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,792 shares of the medical equipment provider’s stock after buying an additional 1,800 shares during the period. Jackson Square Capital LLC’s holdings in Intuitive Surgical were worth $2,501,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of ISRG. State Street Corp increased its holdings in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC increased its stake in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. lifted its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $592.64 on Friday. The firm has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The stock’s fifty day moving average price is $540.66 and its two-hundred day moving average price is $498.77. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.